FR2294702B1 - - Google Patents

Info

Publication number
FR2294702B1
FR2294702B1 FR7537775A FR7537775A FR2294702B1 FR 2294702 B1 FR2294702 B1 FR 2294702B1 FR 7537775 A FR7537775 A FR 7537775A FR 7537775 A FR7537775 A FR 7537775A FR 2294702 B1 FR2294702 B1 FR 2294702B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7537775A
Other languages
French (fr)
Other versions
FR2294702A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2294702A1 publication Critical patent/FR2294702A1/fr
Application granted granted Critical
Publication of FR2294702B1 publication Critical patent/FR2294702B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7537775A 1974-12-16 1975-12-10 Nouvelles 3-cyano pyridines utiles comme medicaments Granted FR2294702A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/533,385 US4000282A (en) 1974-12-16 1974-12-16 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
US05/713,558 US4096151A (en) 1974-12-16 1976-08-11 Certain 3-cyanopyridine intermediates

Publications (2)

Publication Number Publication Date
FR2294702A1 FR2294702A1 (fr) 1976-07-16
FR2294702B1 true FR2294702B1 (US08066781-20111129-C00013.png) 1979-09-28

Family

ID=27064163

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7537775A Granted FR2294702A1 (fr) 1974-12-16 1975-12-10 Nouvelles 3-cyano pyridines utiles comme medicaments

Country Status (11)

Country Link
US (3) US4000282A (US08066781-20111129-C00013.png)
JP (1) JPS5186473A (US08066781-20111129-C00013.png)
AU (1) AU502129B2 (US08066781-20111129-C00013.png)
BE (1) BE836627A (US08066781-20111129-C00013.png)
CA (1) CA1064499A (US08066781-20111129-C00013.png)
DE (2) DE2559755A1 (US08066781-20111129-C00013.png)
FR (1) FR2294702A1 (US08066781-20111129-C00013.png)
GB (2) GB1496579A (US08066781-20111129-C00013.png)
LU (1) LU74000A1 (US08066781-20111129-C00013.png)
NL (1) NL7514164A (US08066781-20111129-C00013.png)
SE (1) SE7513571L (US08066781-20111129-C00013.png)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
US4091104A (en) * 1976-06-15 1978-05-23 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
US4234590A (en) * 1979-02-05 1980-11-18 Merck & Co., Inc. Thiosubstituted pyridines
US4259327A (en) * 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
US4329351A (en) * 1979-10-01 1982-05-11 Merck & Co., Inc. 2-Substituted propoxy-3-cyano-5-RO-pyridines and intermediates
DE2943774A1 (de) * 1979-10-26 1981-05-14 1000 Berlin Schering Ag Berlin Und Bergkamen Substituierte pyridine, verfahren zu ihrer herstellung und ihre verwendung
US4254263A (en) * 1979-11-02 1981-03-03 Merck & Co., Inc. Process for purifying a cyanopyridine compound
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4442094A (en) * 1980-12-23 1984-04-10 Merck & Co., Inc. (3-Aralkylamino-2-or-propoxy)heterocyclic compounds
US4331679A (en) * 1980-12-23 1982-05-25 Merck Sharp & Dohme (I.A.) Corp. (3-Aralkylamino-2-or-propoxy) heterocyclic compounds
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4436740A (en) * 1982-07-26 1984-03-13 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
ES523901A0 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
DE1919342A1 (de) 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano
JPS5839832B2 (ja) * 1974-02-20 1983-09-01 チバ ガイギ− アクチエンゲゼルシヤフト 新規ピラジン化合物の製法
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Also Published As

Publication number Publication date
JPS5186473A (US08066781-20111129-C00013.png) 1976-07-29
SE7513571L (sv) 1976-06-17
NL7514164A (nl) 1976-06-18
US4000282A (en) 1976-12-28
DE2556110C3 (de) 1979-02-22
AU8743675A (en) 1977-06-16
DE2556110A1 (de) 1976-06-24
CA1064499A (en) 1979-10-16
US4096151A (en) 1978-06-20
DE2559755A1 (de) 1977-11-03
GB1496580A (en) 1977-12-30
GB1496579A (en) 1977-12-30
BE836627A (fr) 1976-06-15
US4139535A (en) 1979-02-13
LU74000A1 (US08066781-20111129-C00013.png) 1976-11-11
AU502129B2 (en) 1979-07-12
DE2556110B2 (de) 1978-06-15
FR2294702A1 (fr) 1976-07-16

Similar Documents

Publication Publication Date Title
FR2294702B1 (US08066781-20111129-C00013.png)
FR2273844B1 (US08066781-20111129-C00013.png)
CS176142B2 (US08066781-20111129-C00013.png)
FI751845A (US08066781-20111129-C00013.png)
FR2262081B1 (US08066781-20111129-C00013.png)
JPS50108128A (US08066781-20111129-C00013.png)
JPS50113511A (US08066781-20111129-C00013.png)
AU495028B2 (US08066781-20111129-C00013.png)
JPS50107091U (US08066781-20111129-C00013.png)
JPS50108018A (US08066781-20111129-C00013.png)
JPS50133696U (US08066781-20111129-C00013.png)
JPS50121866U (US08066781-20111129-C00013.png)
JPS50135631U (US08066781-20111129-C00013.png)
JPS50134631A (US08066781-20111129-C00013.png)
BG21327A2 (US08066781-20111129-C00013.png)
BE836964A (US08066781-20111129-C00013.png)
CH576268A5 (US08066781-20111129-C00013.png)
BG20001A1 (US08066781-20111129-C00013.png)
BG20643A1 (US08066781-20111129-C00013.png)
BG21133A1 (US08066781-20111129-C00013.png)
BG21288A1 (US08066781-20111129-C00013.png)
CH575605A5 (US08066781-20111129-C00013.png)
CH578234A5 (US08066781-20111129-C00013.png)
CH595431A5 (US08066781-20111129-C00013.png)
BG21290A1 (US08066781-20111129-C00013.png)

Legal Events

Date Code Title Description
ST Notification of lapse